These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 15585820)

  • 21. Assessment approach for evaluating high abundance protein depletion methods for cerebrospinal fluid (CSF) proteomic analysis.
    Shores KS; Knapp DR
    J Proteome Res; 2007 Sep; 6(9):3739-51. PubMed ID: 17696521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel four-dimensional strategy combining protein and peptide separation methods enables detection of low-abundance proteins in human plasma and serum proteomes.
    Tang HY; Ali-Khan N; Echan LA; Levenkova N; Rux JJ; Speicher DW
    Proteomics; 2005 Aug; 5(13):3329-42. PubMed ID: 16052622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The endogenous peptides of normal human serum extracted from the acetonitrile-insoluble precipitate using modified aqueous buffer with analysis by LC-ESI-Paul ion trap and Qq-TOF.
    Tucholska M; Florentinus A; Williams D; Marshall JG
    J Proteomics; 2010 Apr; 73(6):1254-69. PubMed ID: 20211283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences among techniques for high-abundant protein depletion.
    Zolotarjova N; Martosella J; Nicol G; Bailey J; Boyes BE; Barrett WC
    Proteomics; 2005 Aug; 5(13):3304-13. PubMed ID: 16052628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Utility of electrophoretically derived protein mass estimates as additional constraints in proteome analysis of human serum based on MS/MS analysis.
    Kim JY; Lee JH; Park GW; Cho K; Kwon KH; Park YM; Cho SY; Paik YK; Yoo JS
    Proteomics; 2005 Aug; 5(13):3376-85. PubMed ID: 16052618
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Different immunoaffinity fractionation strategies to characterize the human plasma proteome.
    Gong Y; Li X; Yang B; Ying W; Li D; Zhang Y; Dai S; Cai Y; Wang J; He F; Qian X
    J Proteome Res; 2006 Jun; 5(6):1379-87. PubMed ID: 16739989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of affinity columns for the removal of high-abundance proteins in cerebrospinal fluid.
    Ramström M; Zuberovic A; Grönwall C; Hanrieder J; Bergquist J; Hober S
    Biotechnol Appl Biochem; 2009 Feb; 52(Pt 2):159-66. PubMed ID: 18412540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Profiling of myelin proteins by 2D-gel electrophoresis and multidimensional liquid chromatography coupled to MALDI TOF-TOF mass spectrometry.
    Vanrobaeys F; Van Coster R; Dhondt G; Devreese B; Van Beeumen J
    J Proteome Res; 2005; 4(6):2283-93. PubMed ID: 16335977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Application of 2-D free-flow electrophoresis/RP-HPLC for proteomic analysis of human plasma depleted of multi high-abundance proteins.
    Moritz RL; Clippingdale AB; Kapp EA; Eddes JS; Ji H; Gilbert S; Connolly LM; Simpson RJ
    Proteomics; 2005 Aug; 5(13):3402-13. PubMed ID: 16052629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of cysteinylation of pharmaceutical-grade human serum albumin by electrospray ionization mass spectrometry and low-energy collision-induced dissociation tandem mass spectrometry.
    Kleinova M; Belgacem O; Pock K; Rizzi A; Buchacher A; Allmaier G
    Rapid Commun Mass Spectrom; 2005; 19(20):2965-73. PubMed ID: 16178042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An integrated serum proteomic approach capable of monitoring the low molecular weight proteome with sequencing of intermediate to large peptides.
    Merrell K; Thulin CD; Esplin MS; Graves SW
    Rapid Commun Mass Spectrom; 2009 Sep; 23(17):2685-96. PubMed ID: 19630037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimization of microfabricated nanoliter-scale solid-phase extraction device for detection of gel-separated proteins in low abundance by matrix-assisted laser desorption/ionization mass spectrometry.
    Chen W; Shen J; Yin X; Yu Y
    Rapid Commun Mass Spectrom; 2007; 21(1):35-43. PubMed ID: 17133336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Restricted-access material-based high-molecular-weight protein depletion coupled on-line with nano-liquid chromatography-mass spectrometry for proteomics applications.
    Rieux L; Bischoff R; Verpoorte E; Niederländer HA
    J Chromatogr A; 2007 May; 1149(2):169-77. PubMed ID: 17418220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of potential markers for the detection of pancreatic cancer through comparative serum protein expression profiling.
    Ehmann M; Felix K; Hartmann D; Schnölzer M; Nees M; Vorderwülbecke S; Bogumil R; Büchler MW; Friess H
    Pancreas; 2007 Mar; 34(2):205-14. PubMed ID: 17312459
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The human plasma proteome: analysis of Chinese serum using shotgun strategy.
    He P; He HZ; Dai J; Wang Y; Sheng QH; Zhou LP; Zhang ZS; Sun YL; Liu F; Wang K; Zhang JS; Wang HX; Song ZM; Zhang HR; Zeng R; Zhao X
    Proteomics; 2005 Aug; 5(13):3442-53. PubMed ID: 16047309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reducing agent-mediated precipitation of high-abundance plasma proteins.
    Warder SE; Tucker LA; Strelitzer TJ; McKeegan EM; Meuth JL; Jung PM; Saraf A; Singh B; Lai-Zhang J; Gagne G; Rogers JC
    Anal Biochem; 2009 Apr; 387(2):184-93. PubMed ID: 19454248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distinctive serum protein profiles involving abundant proteins in lung cancer patients based upon antibody microarray analysis.
    Gao WM; Kuick R; Orchekowski RP; Misek DE; Qiu J; Greenberg AK; Rom WN; Brenner DE; Omenn GS; Haab BB; Hanash SM
    BMC Cancer; 2005 Aug; 5():110. PubMed ID: 16117833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biomarker discovery in low-grade breast cancer using isobaric stable isotope tags and two-dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) based quantitative proteomic analysis.
    Bouchal P; Roumeliotis T; Hrstka R; Nenutil R; Vojtesek B; Garbis SD
    J Proteome Res; 2009 Jan; 8(1):362-73. PubMed ID: 19053527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multi-component immunoaffinity subtraction and reversed-phase chromatography of human serum.
    Martosella J; Zolotarjova N
    Methods Mol Biol; 2008; 425():27-39. PubMed ID: 18369884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Identification of serum biomarkers for ovarian cancer using protein chips and time of flight mass spectrometry technology].
    Wang Q; Li L; Li DR; Zhang W; Wei X; Zhang JQ; Tang Y
    Zhonghua Fu Chan Ke Za Zhi; 2006 Aug; 41(8):544-8. PubMed ID: 17083841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.